Commitment towards creating consistent value for our shareholders
Incorporation of a new wholly owned step-down subsidiary in Philippines
CuraTeQ Biologics receives NOC from Health Canada for its biosimilar Dyrupeg
Acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Pvt.Ltd., by Auro Pharma Limited